Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/δ (NR1C2) Antagonist

The Endocrine Society - Tập 22 Số 2 - Trang 523-529 - 2008
Barry G. Shearer1, David J. Steger2, James M. Way3, Thomas B. Stanley3, David C. Lobe3, Didier Grillot4, Marie A. Iannone3, Mitchell A. Lazar2, Timothy M. Willson3, Andrew N. Billin3
1Research and Development, GlaxoSmithKline, Research Triangle Park, NC 27709, USA.
2Division of Endocrinology, Diabetes, and Metabolism (D.J.S., M.A.L.), Department of Medicine, The Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
3GlaxoSmithKline (B.G.S., J.M.W., T.B.S., D.C.L., M.A.I., T.M.W., A.N.B.), Research and Development, Research Triangle Park, North Carolina 27709
4GlaxoSmithKline (D.A.G.), Research and Development, 91951 Les Ulis, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Endocrine Society

Tập 22 Số 2

523-529

Thông tin tác giả